-
Add to Cart The item has been addedM659449-1mgMAL-di-EG-Val-Cit-PAB-MMAF consists the ADCs linker (MAL-di-EG-Val-Cit-PAB) and potent tubulin polymerization blocker (MMAF, Monomethyl auristatin F).Appearance:SolidIC50&: Target:AuristatinBiological Activity:MAL-di-EG-Val-Cit-PAB-MMAF consists -
Add to Cart The item has been addedM659449-5mgMAL-di-EG-Val-Cit-PAB-MMAF consists the ADCs linker (MAL-di-EG-Val-Cit-PAB) and potent tubulin polymerization blocker (MMAF, Monomethyl auristatin F).Appearance:SolidIC50&: Target:AuristatinBiological Activity:MAL-di-EG-Val-Cit-PAB-MMAF consists -
Add to Cart The item has been addedM647853-1mgMal-PEG2-VCP-Eribulin consists the ADCs linker (Mal-PEG2-VCP) and Eribulin Eribulin is a mechanistically unique microtubule inhibitor for cancer . Mal-PEG2-VCP-Eribulin is an Eribulin-based agent for antibody conjugatesForm:SolidIC50&: -
Add to Cart The item has been addedM647853-5mgMal-PEG2-VCP-Eribulin consists the ADCs linker (Mal-PEG2-VCP) and Eribulin Eribulin is a mechanistically unique microtubule inhibitor for cancer . Mal-PEG2-VCP-Eribulin is an Eribulin-based agent for antibody conjugatesForm:SolidIC50&: -
Add to Cart The item has been addedM646383-1mgMal-PEG4-VA-PBD is a agent-linker conjugate for ADC by using the antitumor antibiotic , Pyrrolobenzodiazepine (PBD), linked via Mal-PEG4-VA.IC50&: Target:Pyrrolobenzodiazepines. -
Add to Cart The item has been addedM646673-1mgMal-PEG4-VC-PAB-DMEA-PNU-159682, a agent-linker conjugate for ADC , consists the ADC linker Mal-PEG4-VC-PAB and a potent ADC cytotoxin DMEA-PNU-159682. DMEA-PNU-159682 includes metabolites of nemorubicin (MMDX) from liver microsomes and ADC -
Add to Cart The item has been addedM646673-5mgMal-PEG4-VC-PAB-DMEA-PNU-159682, a agent-linker conjugate for ADC , consists the ADC linker Mal-PEG4-VC-PAB and a potent ADC cytotoxin DMEA-PNU-159682. DMEA-PNU-159682 includes metabolites of nemorubicin (MMDX) from liver microsomes and ADC -
Add to Cart The item has been addedM646724-10mgAladdin
Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan (C09-1152-292)
Price: $2,020.27List Price: $2,244.74Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan is a conjugate used to synthesis ADC. Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan comprises topoisomerase inhibitor derivative with a linker for connecting to a ligand unit (extracted from patent -
Add to Cart The item has been addedM646724-1mgMal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan is a conjugate used to synthesis ADC. Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan comprises topoisomerase inhibitor derivative with a linker for connecting to a ligand unit (extracted from patent -
Add to Cart The item has been addedM646724-5mgAladdin
Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan (C09-1152-294)
Price: $1,261.08List Price: $1,401.20Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan is a conjugate used to synthesis ADC. Mal-PEG8-amide-Val-Ala-(4-NH2)-Exatecan comprises topoisomerase inhibitor derivative with a linker for connecting to a ligand unit (extracted from patent -
Add to Cart The item has been addedM658904-1mgMal-PEG8-Phe-Lys-PAB-Exatecan TFA is a agent-linker conjugate for ADC, composed of degradable linker Mal-PEG8-Phe-Lys-PAB and toxin molecule Exatecan ( HY-13631 ).Appearance:SolidBiological Activity:Mal-PEG8-Phe-Lys-PAB-Exatecan TFA is a -
Add to Cart The item has been addedM658904-5mgMal-PEG8-Phe-Lys-PAB-Exatecan TFA is a agent-linker conjugate for ADC, composed of degradable linker Mal-PEG8-Phe-Lys-PAB and toxin molecule Exatecan ( HY-13631 ).Appearance:SolidBiological Activity:Mal-PEG8-Phe-Lys-PAB-Exatecan TFA is a
